Spondyloarthritis & psoriatic arthritis
Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project
Authors' conclusion
DAPSA44 demonstrated the most adequate measurement performance across axSpA and pSpA and was endorsed by ASAS as the recommended instrument for assessing disease activity related to peripheral arthritis in pSpA clinical research.
Study context
- Population
- Axial spondyloarthritis (axSpA) and peripheral spondyloarthritis (pSpA) with peripheral arthritis, clinical research13 randomised controlled trials (RCTs)
- Comparison
- Candidate instruments for peripheral arthritis disease activity: composite instruments (Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Axial Spondyloarthritis Disease Activity Score (ASDAS), DAPSA44) vs single-item measures and joint counts
- Outcome
- Most appropriate instrument to assess disease activity related to peripheral arthritis in axSpA and pSpA
Methodological detailsOMERACT framework, two systematic literature review (SLRs), individual patient data from RCTs, working group discussion, ASAS consensus voting
- OMERACT framework
- Two SLRs
- Individual patient data from RCTs
- Working group discussion
- ASAS consensus voting
Recommendations
As reported in the abstract
Instrument selection
ASAS voting agreement for DAPSA44 as preferred instrument, axSpA
92%
ASAS voting agreement for DAPSA44 as preferred instrument, pSpA
97%
Original publication
Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project. Ann Rheum Dis. Published 7 July 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →